top of page

2024 and Beyond: Will Cannabis Be Rescheduled This Year?

As we step into 2024, one of the burning questions on the minds of many in the cannabis industry and among advocates is whether this will be the year that cannabis is rescheduled. This potential shift could mark a significant change in how cannabis is regulated and perceived at the federal level in the United States.

Current Status

Cannabis is currently classified as a Schedule I substance under the Controlled Substances Act. This classification is reserved for drugs that are considered to have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. This places cannabis in the same category as heroin and LSD, a stance that has been increasingly criticized as more states legalize medical and recreational cannabis.

The Push for Rescheduling

The movement to reschedule cannabis has gained momentum over recent years, driven by:

  • Increasing Acceptance: A growing number of states have legalized cannabis for medical and recreational use, which contradicts its Schedule I classification.

  • Medical Research: Research continues to reveal the medical benefits of cannabis, supporting its use in treating a wide range of conditions from chronic pain to epilepsy.

  • Public Opinion: Public support for legalized cannabis has reached an all-time high, with a significant portion of the population advocating for loosened restrictions.

Potential Benefits of Rescheduling

Rescheduling cannabis could have widespread implications:

  • Medical Access and Research: Moving cannabis to a lower schedule would facilitate more research and make it easier for medical patients to access it as a treatment option.

  • Economic Impact: Legalization and rescheduling could further stimulate economic growth, generating jobs and tax revenue.

  • Criminal Justice Reform: It could lead to reduced incarceration rates for cannabis-related offenses, significantly impacting lives and addressing racial disparities in drug-related arrests.

Challenges and Considerations

Despite the strong advocacy, rescheduling faces several challenges:

  • Political Hurdles: Changes at the federal level require significant political will and consensus, which can be difficult to achieve.

  • Regulatory Adjustments: Rescheduling would necessitate a reevaluation of existing laws and regulations governing the production, distribution, and sale of cannabis.


The question of whether cannabis will be rescheduled in 2024 remains open, dependent on legislative, judicial, and executive actions. However, given the current trajectory of public opinion and state-level legalization, it seems increasingly possible that change is on the horizon.